Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Evoke Pharma Inc (EVOK) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Evoke Pharma Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1403708.
Total stock buying since 2014: $2,502,800.
Total stock sales since 2014: $3,385,252.
Total stock option exercises since 2014: $48,722.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 41 | $179 | 0 | $0 |
| 2020 | 0 | $0 | 118,000 | $343,841 | 118,000 | $47,200 |
| 2018 | 500,000 | $1,175,000 | 0 | $0 | 0 | $0 |
| 2017 | 450,000 | $1,305,000 | 0 | $0 | 0 | $0 |
| 2016 | 0 | $0 | 511,413 | $2,495,476 | 0 | $0 |
| 2015 | 0 | $0 | 75,751 | $545,756 | 0 | $0 |
| 2014 | 4,000 | $22,800 | 0 | $0 | 5,250 | $1,522 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-01 | 0 | $0 | 41 | $179 | 0 | $0 |
| 2020-12 | 0 | $0 | 118,000 | $343,841 | 118,000 | $47,200 |
| 2018-08 | 500,000 | $1,175,000 | 0 | $0 | 0 | $0 |
| 2017-02 | 450,000 | $1,305,000 | 0 | $0 | 0 | $0 |
| 2016-05 | 0 | $0 | 355,880 | $1,672,636 | 0 | $0 |
| 2016-04 | 0 | $0 | 155,533 | $822,840 | 0 | $0 |
| 2015-08 | 0 | $0 | 23,874 | $167,594 | 0 | $0 |
| 2015-04 | 0 | $0 | 51,877 | $378,162 | 0 | $0 |
| 2014-09 | 4,000 | $22,800 | 0 | $0 | 5,250 | $1,522 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-28 | Mack Daniel | Sale | 41 | 4.39 | 179 |
| 2020-12-14 | Gonyer David A (President and CEO) | Sale | 23,954 | 2.94 | 70,424 |
| 2020-12-11 | D'onofrio Matthew J (Exec VP, Chief Bus. Officer) | Sale | 40,357 | 2.91 | 117,438 |
| 2020-12-11 | Gonyer David A (President and CEO) | Sale | 48,046 | 2.90 | 139,333 |
| 2020-12-10 | D'onofrio Matthew J (Exec VP, Chief Bus. Officer) | Sale | 5,643 | 2.95 | 16,646 |
| 2020-12-09 | D'onofrio Matthew J (Exec VP, Chief Bus. Officer) | Option Ex | 46,000 | .40 | 18,400 |
| 2020-12-09 | Gonyer David A (President and CEO) | Option Ex | 72,000 | .40 | 28,800 |
| 2018-08-20 | Lvpmc, Llc (10% Owner) | Buy | 500,000 | 2.35 | 1,175,000 |
| 2017-02-22 | Widder Kenneth J (Director) | Buy | 450,000 | 2.90 | 1,305,000 |
| 2016-05-26 | Halak Brian K (10% Owner) | Sale | 350,000 | 4.70 | 1,645,000 |
| 2016-04-27 | Halak Brian K (10% Owner) | Sale | 3,664 | 5.02 | 18,393 |
| 2016-04-25 | Halak Brian K (10% Owner) | Sale | 1,513 | 5.20 | 7,867 |
| 2016-04-20 | Halak Brian K (10% Owner) | Sale | 4,500 | 5.29 | 23,804 |
| 2016-04-19 | Halak Brian K (10% Owner) | Sale | 37,686 | 5.36 | 201,996 |
| 2016-04-11 | Halak Brian K (10% Owner) | Sale | 4,423 | 5.22 | 23,087 |
| 2016-04-08 | Halak Brian K (10% Owner) | Sale | 14,805 | 5.35 | 79,205 |
| 2016-04-07 | Halak Brian K (10% Owner) | Sale | 28,256 | 5.26 | 148,626 |
| 2016-04-06 | Halak Brian K (10% Owner) | Sale | 8,817 | 5.22 | 46,024 |
| 2015-08-18 | Halak Brian K (10% Owner) | Sale | 12,038 | 7.02 | 84,506 |
| 2015-04-16 | Halak Brian K (10% Owner) | Sale | 32,965 | 7.07 | 233,061 |
| 2015-04-15 | Halak Brian K (10% Owner) | Sale | 8,055 | 7.58 | 61,056 |
| 2015-04-14 | Halak Brian K (10% Owner) | Sale | 10,000 | 7.78 | 77,799 |
| 2014-09-23 | Brady Todd C (Director) | Buy | 4,000 | 5.70 | 22,800 |
| 2014-09-03 | Hill Malcolm R (Director) | Option Ex | 5,250 | .29 | 1,522 |
Insider trading activities including stock purchases, stock sales, and option exercises of EVOK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Evoke Pharma Inc (symbol EVOK, CIK number 1403708) see the Securities and Exchange Commission (SEC) website.